What is Forty Seven Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Forty Seven's interest expense for the
three
months ended in Dec. 2019 was $ 0.00 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Dec. 2019 was $0.00 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Forty Seven's Operating Income for the
three
months ended in Dec. 2019 was $ -24.56 Mil. Forty Seven's Interest Expense for the
three
months ended in Dec. 2019 was $ 0.00 Mil.
GuruFocus does not calculate Forty Seven's interest coverage with the available data.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Forty Seven Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Forty Seven (NAS:FTSV) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Forty Seven's Interest Expense for the
three
months ended in Dec. 2019 was $0.00 Mil. Its
Operating Income
for the
three
months ended in Dec. 2019 was $-24.56 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Dec. 2019 was $0.84 Mil.
Forty Seven's Interest Coverage for the quarter that ended in Dec. 2019 is calculated as
| GuruFocus does not calculate Forty Seven's interest coverage with the available data. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Forty Seven (Forty Seven) Business Description
Traded in Other Exchanges
N/A
Address
1490 O’Brien Drive, Suite A, Menlo Park, CA, USA, 94025
Forty Seven Inc is a clinical-stage immuno-oncology company. It is engaged in developing novel checkpoint therapies to activate macrophages and help the patients in their fight against cancer. It founded that blocking CD47, a key signaling molecule that is overexpressed on cancer cells renders tumors susceptible to macrophages. It is also preparing investigational compounds into clinical testing. FSI-174, an anti-cKIT antibody, is being developed in combination with magrolimab as a novel, all-antibody conditioning regimen to address the limitations of current stem cell transplantation conditioning regimens. FSI-189, an anti-SIRP-alpha antibody, is being developed for the treatment of cancer, and certain non-oncology conditions, including transplantation conditioning.
Executives
| Dennis Henner |
director |
THE JOHN HANCOCK TOWER, 200 CLARENDON STREET, 54TH FLOOR, BOSTON MA 02116 |
| Kristine M Ball |
director |
C/O RELYPSA, INC., 700 SAGINAW DRIVE, REDWOOD CITY CA 94063 |
| Ann D Rhoads |
officer: Chief Financial Officer |
4000 NORTH FIRST STREET, SAN JOSE CA 95134 |
| Ian T Clark |
director |
SOLAZYME, INC., 225 GATEWAY BLVD., SOUTH SAN FRANCISCO CA 94080 |
| Jeffrey W Bird |
director |
755 PAGE MILL RD STE A-200, PALO ALTO CA 94304-1005 |
| Lightspeed General Partner X, L.p. |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Lightspeed Ultimate General Partner X, Ltd. |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Jeremy Liew |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Lightspeed Venture Partners X, L.p. |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Barry Eggers |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Peter Nieh |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Ravi Mhatre |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Stephen A Schwarzman |
10 percent owner |
C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154 |
| Blackstone Clarus Iii L.l.c. |
10 percent owner |
C/O THE BLACKSTONE GROUP L.P., 345 PARK AVENUE, NEW YORK NY 10154 |
| Blackstone Inc. |
10 percent owner |
345 PARK AVENUE, NEW YORK NY 10154 |
Forty Seven (Forty Seven) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FTSV has been successfully added to your 